ArticleMolecular cancer therapeutics2022

Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells.

Lichao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.